FOR IMMEDIATE RELEASE 13 MARCH 2008
CHEMRING GROUP PLC
KILGORE AWARDED M212 FLARE CONTRACT
Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiary,
Kilgore Flares Company LLC ("Kilgore"), based in Toone, Tennessee, has been
awarded an IDIQ (indefinite delivery/indefinite quantity) contract for the
supply of M212 flares to the US Department of Defense. The M212 flare is a key
component in the Advanced Infrared Countermeasure Munition (AIRCMM) suite that
is used by the US Army and US Air Force to protect helicopters from the threat
of IR guided missiles. The contract extends over a five year period, and has a
minimum value of $5.4 million and a maximum value of $382.9 million.
Dr David Price, Chief Executive of Chemring, commented: "We are delighted to
have won the competition for the M212 flare. This is a tremendous achievement
by our US subsidiary, which extends our product portfolio and significantly
enhances our long term position in the US market. The contract is the largest
ever framework contract awarded to Chemring by the US Department of Defense."
Chemring is an international leader in defensive countermeasures and energetic
materials. The countermeasures division comprises Alloy Surfaces Company, Inc.
and Kilgore Flares Company LLC in the US, and Chemring Countermeasures Limited
in the UK.
For further information:
Dr David Price Chief Executive, Chemring Group PLC 01489 881880
Paul Rayner Finance Director, Chemring Group PLC 01489 881880
Rupert Pitman Cardew Group 0207 930 0777
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.